Valentine Grumberg

5PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2023
Organizational Impact of Immunotherapies in Advanced Cancers in France.

Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin

|May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.

Valentine Grumberg, Christos Chouaïd, François-Emery Cotté

|Mar 25, 2022
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities.

Valentine Grumberg, Stéphane Roze, Julie Chevalier

|Feb 03, 2022
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Christos Chouaïd, Valentine Grumberg, Alexandre Batisse

|Sep 11, 2020
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study.

François-Emery Cotté, Paméla Voillot, Bryan Bennett

Pageof 1